InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Rachman Ilya M, Chairman & CEO. Director active across 1 companies, notably Immix Biopharma, Inc.. In total, 2 disclosures have been recorded. Total volume traded: €22k. The latest transaction was filed on 20 December 2021 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
€11,1172,500 shares@ €4.447100.0% of flow
Common Stock
SEC:0001493152-21-032038·
Ideal exit: 16 Sept 2022 (T+270)
€11,1172,500 shares@ €4.4470.0021% mcap50.0% of flow
Common Stock
SEC:0001493152-21-032038:0·
Ideal exit: 16 Sept 2022 (T+270)
2 of 2 declarations
About Rachman Ilya M
Ilya M. Rachman is the CEO and Chairman of Immix Biopharma, Inc., a biopharmaceutical company. He oversees the strategic direction of the company and manages its operations. His expertise in the biopharmaceutical sector allows him to lead initiatives aimed at developing new treatments and improving patient outcomes.
